Transjugular Liver Biopsy and Hepatic Vein Pressure Gradient

Transjugular Liver Biopsy and Hepatic Vein Pressure Gradient

  • Transjugular liver biopsy (TJLB) is an alternative to a percutaneous liver biopsy.
  • Specimens obtained from TJLB have a reduced risk of hemorrhage compared to those obtained with the percutaneous technique. ‹ Its clinical role has expanded due to the possibility of performing hemodynamic evaluation.
  • TJLB is indicated in failed percutaneous liver biopsy or in a patient with a contraindication to percutaneous biopsy, in coagulopathy (a most common indication), massive ascites, patients requiring hemodynamic evaluation as part of their diagnostic workup, morbid obesity, liver transplant or with serum bilirubin >6, in patients undergoing a TIPS procedure.
  • There are no real contraindications for a TJLB. However, relative contraindications include a lack of suitable venous access and a biopsy of a focal lesion.
  • An international normalized ratio (INR) of >2 and a platelet count of 2.5 times the control and the platelet count is 10 mmHg indicates CSPH.
  • Patients with CSPH are at high risk of developing clinical complications, including variceal bleeding, ascites and encephalopathy.
  • While a biopsy sample represents only a small liver area, serial HVPG measurements characterize the overall degree of fibrosis or cirrhosis, reflecting an underlying heterogeneous disease process.
  • HVPG is the gold standard for PHT measurement, and its safety and reproducibility are well-proven. It has become an important diagnostic and prognostic tool and can be adopted in routine practices as per the Baveno VII consensus.

IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.

 More FAQs by IJCP Editorial Team


Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks